Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Neuroreport|February 8, 2017
Hippocampal infusion of lipopolysaccharide induces immune responses and results in seizures in ratsYanxiang Zhang, Xuwen Sun, Yu Nai, et al.
Journal of Alzheimer'S Disease : JAD|March 17, 2025
Synergistic associations of amyloid-β and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's diseaseChunhua Zhang, Yaojun Tai, Min Kong, et al.
Oncotarget|September 17, 2017
An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's diseaseMin Kong, Maowen Ba, Chao Ren, et al.
Translational Neurodegeneration|November 29, 2016
Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?Maowen Ba, Min Kong, Xiaofeng Li, et al.
Journal of Integrative Neuroscience|January 8, 2022
Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's diseaseYi Chen, Joseph Therriault, Jing Luo, et al.
Frontiers in Aging Neuroscience|December 26, 2025
Amyloid pathology modulates the relationship between subsyndromal symptomatic depression and tau accumulation in non-demented older adultsJiahe Bai, Xiaonan Wei, Hongchun Wei, et al.
The European Journal of Neuroscience|May 3, 2024
Predicting amyloid-PET and clinical conversion in apolipoprotein E ε3/ε3 non-demented individuals with multidimensional factorsLijuan Xu, Chao Ren, Chenxi Jing, et al.
Journal of Alzheimer'S Disease : JAD|March 30, 2026
Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairmentXitian Wang, Chunhua Zhang, Xiaocong Liu, et al.
Pageof 4